CO5170487A1 - Inhaladores presurizados de dosis medidas (mdi) - Google Patents
Inhaladores presurizados de dosis medidas (mdi)Info
- Publication number
- CO5170487A1 CO5170487A1 CO99074044A CO99074044A CO5170487A1 CO 5170487 A1 CO5170487 A1 CO 5170487A1 CO 99074044 A CO99074044 A CO 99074044A CO 99074044 A CO99074044 A CO 99074044A CO 5170487 A1 CO5170487 A1 CO 5170487A1
- Authority
- CO
- Colombia
- Prior art keywords
- mdi
- measures
- dose inhalers
- pressure dose
- pressure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
Abstract
INHALADORES PRESURIZADOS DE DOSIS MEDIDAS (MDI).La invención se refiere al uso de inhaladores presurizados de dosis medidas (MDI) que tienen parte o la totalidad de sus superficies internas de acero inoxidable, aluminio anodizado o están revestidas con una cubierta orgánica inerte; y a las composiciones que se deben administrar con dichos MDI.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI982559 IT1303789B1 (it) | 1998-11-25 | 1998-11-25 | "inalatori dosati pressurizzati" |
IT1999MI001712 IT1313582B1 (it) | 1999-07-30 | 1999-07-30 | Inalatori dosati pressurizzati. |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5170487A1 true CO5170487A1 (es) | 2002-06-27 |
Family
ID=26331622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99074044A CO5170487A1 (es) | 1998-11-25 | 1999-11-24 | Inhaladores presurizados de dosis medidas (mdi) |
Country Status (36)
Country | Link |
---|---|
US (8) | US7347199B1 (es) |
EP (4) | EP1131051B1 (es) |
JP (1) | JP2002530156A (es) |
KR (1) | KR100696746B1 (es) |
CN (1) | CN1200690C (es) |
AR (1) | AR021391A1 (es) |
AT (2) | ATE314838T1 (es) |
AU (1) | AU764696C (es) |
BG (1) | BG65596B1 (es) |
BR (1) | BR9916868B1 (es) |
CA (2) | CA2698376A1 (es) |
CO (1) | CO5170487A1 (es) |
CY (1) | CY1105356T1 (es) |
CZ (1) | CZ301305B6 (es) |
DE (3) | DE69929358T2 (es) |
DK (1) | DK1131051T3 (es) |
DZ (1) | DZ2947A1 (es) |
EA (1) | EA004132B1 (es) |
EE (1) | EE04259B1 (es) |
EG (1) | EG25278A (es) |
ES (1) | ES2255767T3 (es) |
GE (1) | GEP20033129B (es) |
HK (1) | HK1040063B (es) |
HU (1) | HU226735B1 (es) |
IL (3) | IL143294A0 (es) |
MA (1) | MA26764A1 (es) |
NO (1) | NO330194B1 (es) |
NZ (2) | NZ527190A (es) |
PL (2) | PL204572B1 (es) |
SA (1) | SA99200825B1 (es) |
SI (1) | SI1131051T1 (es) |
SK (1) | SK285246B6 (es) |
TN (1) | TNSN99220A1 (es) |
TR (2) | TR200101441T2 (es) |
TW (1) | TWI226247B (es) |
WO (1) | WO2000030608A1 (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
SE9703407D0 (sv) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6739333B1 (en) | 1999-05-26 | 2004-05-25 | Boehringer Ingelheim Pharma Kg | Stainless steel canister for propellant-driven metering aerosols |
US6315985B1 (en) * | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317720B1 (it) * | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
IT1317846B1 (it) * | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
HU230804B1 (hu) | 2000-05-22 | 2018-06-28 | Chiesi Farmaceutici S.P.A | Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére |
DE10062712A1 (de) * | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
US20020085978A1 (en) * | 2000-11-10 | 2002-07-04 | Mina Buenafe | Degradation-resistant glucocorticosteroid formulations |
EP1241113A1 (en) | 2001-03-12 | 2002-09-18 | CHIESI FARMACEUTICI S.p.A. | Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
GB0106046D0 (en) | 2001-03-12 | 2001-05-02 | Glaxo Group Ltd | Canister |
DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
ATE267591T1 (de) * | 2001-07-02 | 2004-06-15 | Chiesi Farma Spa | Optimierte tobramycin-formulierung zur aerosolbildung |
EP1321159A1 (en) | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices |
JP2005523905A (ja) * | 2002-03-01 | 2005-08-11 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | ホルモテロール(formoterol)超微細調合物 |
EP1415647A1 (en) * | 2002-10-23 | 2004-05-06 | CHIESI FARMACEUTICI S.p.A. | "Long-acting beta-2 agonists ultrafine formulations" |
EP1340492A1 (en) * | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
US20040126325A1 (en) * | 2002-03-12 | 2004-07-01 | David Lewis | Medicinal aerosol solution formulation products with improved chemical stability |
DE10214263A1 (de) * | 2002-03-28 | 2003-10-16 | Boehringer Ingelheim Pharma | HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum |
JP2006516545A (ja) * | 2003-02-04 | 2006-07-06 | クリサリス テクノロジーズ インコーポレイテッド | パーフルオロカーボン及びハイドロフルオロカーボン製剤及びその製法及び使用法 |
EP1915985A1 (en) | 2003-03-20 | 2008-04-30 | Boehringer Ingelheim Pharmaceuticals Inc. | Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants |
RS51663B (en) | 2003-03-20 | 2011-10-31 | Boehringer Ingelheim Pharmaceuticals Inc. | DOSAGE FORMULATION INHALATOR USING HYDRO-FLUORO-ALKAN AS PROPELLENT |
GB0311701D0 (en) * | 2003-05-21 | 2003-06-25 | Karib Kemi Pharm Liited | Improved metered dose inhaler product |
EP1641682B1 (en) | 2003-06-24 | 2011-01-05 | Cipla Limited | Pharmaceutical dispensing aid |
US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
DE10345065A1 (de) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
WO2005041931A2 (en) * | 2003-10-20 | 2005-05-12 | Schering Corporation | Pharmaceutical aerosol compositions |
UA88894C2 (ru) * | 2004-02-27 | 2009-12-10 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Стабильные фармацевтические композиции в виде растворов для ингаляторов с дозатором, которые находятся под давлением |
EP1595531A1 (en) * | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
IL177103A0 (en) * | 2004-02-27 | 2006-12-10 | Chiesi Farma Spa | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
AU2005259523B2 (en) | 2004-07-02 | 2011-06-09 | Boehringer Ingelheim International Gmbh | Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant |
JP5259193B2 (ja) | 2005-02-25 | 2013-08-07 | チエシイ・ファルマセウテイシイ・エス・ペー・アー | 加圧下にある用量計量型吸入器用の金属イオン封鎖剤を含む薬用エーロゾル配合物 |
EP2484382A1 (en) * | 2005-03-30 | 2012-08-08 | Schering Corporation | Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form |
DE102006017320A1 (de) | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
US8227027B2 (en) | 2007-12-07 | 2012-07-24 | Presspart Gmbh & Co. Kg | Method for applying a polymer coating to an internal surface of a container |
EP2547335A4 (en) | 2010-03-15 | 2014-04-16 | Univ Virginia Commonwealth | AEROSOLIC DAPSONE AS THERAPY AGAINST INFLAMMATION OF THE RESPIRATORY SYSTEM AND ANOMALY OF MUCOCILIARY TRANSPORT |
CA2805700A1 (en) * | 2010-07-16 | 2012-01-19 | Cipla Limited | Pharmaceutical compositions comprising r(+) budesonide and formoterol |
TWI399202B (zh) | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
GB201108039D0 (en) * | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
CN102379846B (zh) * | 2011-10-21 | 2014-07-02 | 江苏长风药业有限公司 | 以氢氟烷烃和聚乙二醇为辅料氟替卡松丙酸酯气雾剂制剂 |
GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
CN103207032A (zh) * | 2012-01-13 | 2013-07-17 | 热敏碟公司 | 低型面温度传感器探针 |
KR101313993B1 (ko) * | 2012-07-24 | 2013-10-01 | 한국화학연구원 | 약물 흡입 장치 |
DE102013214601B3 (de) | 2013-07-25 | 2014-05-22 | Aptar Radolfzell Gmbh | Gehäuse für eine Inhalationsvorrichtung und Inhalationsvorrichtung zur oralen Verabreichung eines pharmazeutischen Mediums |
US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
CA3111682A1 (en) * | 2014-06-26 | 2015-12-30 | Island Breeze Systems Ca, Llc | Mdi related products and methods of use |
CN114111983A (zh) | 2014-09-08 | 2022-03-01 | 贝克顿·迪金森公司 | 用于制备药物化合物的***和方法 |
CN106620976B (zh) * | 2016-12-28 | 2020-01-07 | 四川普锐特医药科技有限责任公司 | 一种丙酸氟替卡松定量吸入气雾剂 |
US10231948B2 (en) | 2017-02-27 | 2019-03-19 | Jason Ty Nguyen | Metered dose inhaler compositions, systems, and methods |
EP3806939B1 (en) * | 2018-06-13 | 2024-04-10 | Puff-Ah Pty Ltd | Apparatus for use in delivering respiratory drugs |
Family Cites Families (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US220718A (en) * | 1879-10-21 | Improvement in street-car warmers | ||
US154013A (en) * | 1874-08-11 | Improvement in carriage-lamps | ||
BE555319A (es) * | 1956-03-21 | 1900-01-01 | ||
US3361306A (en) * | 1966-03-31 | 1968-01-02 | Merck & Co Inc | Aerosol unit dispensing uniform amounts of a medically active ingredient |
CA882187A (en) | 1968-03-13 | 1971-09-28 | Farbenfabriken Bayer Aktiengesellschaft | Thermoplastic-elastic moulding compounds |
US3622053A (en) * | 1969-12-10 | 1971-11-23 | Schering Corp | Aerosol inhaler with flip-up nozzle |
MX3864E (es) | 1975-05-27 | 1981-08-26 | Syntex Corp | Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona |
US4185100A (en) | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
US4499108A (en) | 1983-06-08 | 1985-02-12 | Schering Corporation | Stable pleasant-tasting albuterol sulfate pharmaceutical formulations |
GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
IT1196142B (it) | 1984-06-11 | 1988-11-10 | Sicor Spa | Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti |
US4584320A (en) * | 1985-01-03 | 1986-04-22 | David Rubin | Anti-asthmatic composition and method using 8,11,14,17-eicosatetraenoic acid |
US5192528A (en) | 1985-05-22 | 1993-03-09 | Liposome Technology, Inc. | Corticosteroid inhalation treatment method |
US5225183A (en) * | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
GB8828477D0 (en) | 1988-12-06 | 1989-01-05 | Riker Laboratories Inc | Medical aerosol formulations |
IL97065A (en) | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
WO1991012596A1 (de) | 1990-02-14 | 1991-08-22 | Systec Ausbausysteme Gmbh | Transportwagen mit münzschloss |
IT1244441B (it) * | 1990-09-13 | 1994-07-15 | Chiesi Farma Spa | Dispositivo per l'inalazione boccale di farmaci aerosol |
CA2098298A1 (en) | 1990-12-19 | 1992-06-20 | Susan M. Milosovich | Aerosol formulations |
US6006745A (en) * | 1990-12-21 | 1999-12-28 | Minnesota Mining And Manufacturing Company | Device for delivering an aerosol |
US5190029A (en) * | 1991-02-14 | 1993-03-02 | Virginia Commonwealth University | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
EP0504112A3 (en) | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
EP0585379B1 (en) | 1991-05-21 | 1998-09-30 | Abbott Laboratories | Aerosol inhalation device |
CA2116579A1 (en) * | 1991-08-29 | 1993-03-18 | Christoph Klein | Medical device for inhaling doses of spray |
IL103238A (en) | 1991-09-25 | 1995-07-31 | Fisons Plc | Pressed aerosol preparations |
US5219882A (en) | 1991-10-24 | 1993-06-15 | Emil Bisaccia | Treatment methods for lymes disease and associated debilitating conditions |
IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
NZ246421A (en) | 1991-12-18 | 1996-05-28 | Minnesota Mining & Mfg | Aerosol formulation containing a drug and a propellant and which is substantially free of surfactant |
DE4230876A1 (de) | 1992-03-17 | 1993-09-23 | Asta Medica Ag | Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten |
WO1994013263A1 (en) | 1992-12-09 | 1994-06-23 | Jager Paul D | Stabilized medicinal aerosol solution formulations |
SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
AU4066693A (en) | 1992-12-23 | 1994-07-19 | Bernhard Hugemann | Compacted drug body for use in the mechanical generation of inhalable active-substance particles |
DE69413955T2 (de) | 1993-03-17 | 1999-04-01 | Minnesota Mining & Mfg | Aerosolzusammensetzung enthaltend einen aus ester-, amid- oder merkaptoester- derivat dispergiermittel |
AU679510B2 (en) | 1993-03-17 | 1997-07-03 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing a diol-diacid derived dispersing aid |
US5899201A (en) * | 1993-05-26 | 1999-05-04 | Minnesota Mining And Manufacturing Company | Aerosol actuator |
US6596260B1 (en) * | 1993-08-27 | 2003-07-22 | Novartis Corporation | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
WO1995017195A1 (en) * | 1993-12-20 | 1995-06-29 | Minnesota Mining And Manufacturing Company | Flunisolide aerosol formulations |
US5508269A (en) * | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
GB9425160D0 (en) | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
NZ298169A (en) | 1994-12-22 | 1999-09-29 | Astra Ab | Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant |
GB9426252D0 (en) | 1994-12-24 | 1995-02-22 | Glaxo Group Ltd | Pharmaceutical composition |
DE4446891A1 (de) | 1994-12-27 | 1996-07-04 | Falk Pharma Gmbh | Stabile wäßrige Budesonid-Lösung |
US5653961A (en) | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
CA2361954C (en) * | 1995-04-14 | 2003-07-08 | Smithkline Beecham Corporation | Metered dose inhaler for albuterol |
BR9604977A (pt) | 1995-04-14 | 1998-06-09 | Glaxo Wellcome Inc | Inalador de dose medida sistema inalador de dose medida e uso do mesmo |
EE04004B1 (et) * | 1995-04-14 | 2003-04-15 | Glaxo Wellcome Inc. | Flutikasoonpropionaati doseeriv inhalaator |
KR19980703850A (ko) * | 1995-04-14 | 1998-12-05 | 그레이엄브레레톤 | 베클로메타손 디프로피오네이트용 계량 흡입기 |
US5637505A (en) * | 1995-05-19 | 1997-06-10 | Chiron Diagnostics Corporation | Method to prepare dye-based reference material |
GB9526392D0 (en) * | 1995-12-22 | 1996-02-21 | Glaxo Group Ltd | Medicaments |
GB9612297D0 (en) | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
WO1998001147A1 (en) | 1996-07-08 | 1998-01-15 | Rhone-Poulenc Rorer Limited | Medicinal cyclosporin-a aerosol solution formulation |
WO1998003533A1 (en) | 1996-07-24 | 1998-01-29 | Oligos Etc. And Oligos Therapeutics, Inc. | Antisense oligonucleotides as antibacterial agents |
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
GB9620187D0 (en) | 1996-09-27 | 1996-11-13 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
CA2273835A1 (en) * | 1996-12-04 | 1998-06-11 | Bioglan Ireland (R & D) Limited | Pharmaceutical compositions and devices for their administration |
US6413496B1 (en) | 1996-12-04 | 2002-07-02 | Biogland Ireland (R&D) Limited | Pharmaceutical compositions and devices for their administration |
AUPO429396A0 (en) * | 1996-12-20 | 1997-01-23 | Solsearch Pty Ltd | Solar energy collector system |
WO1998034595A1 (de) * | 1997-02-05 | 1998-08-13 | Jago Research Ag | Medizinische aerosolformulierungen |
US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
US6129905A (en) * | 1997-04-21 | 2000-10-10 | Aeropharm Technology, Inc. | Aerosol formulations containing a sugar as a dispersant |
US5891419A (en) | 1997-04-21 | 1999-04-06 | Aeropharm Technology Limited | Environmentally safe flunisolide aerosol formulations for oral inhalation |
CN1213778C (zh) | 1997-06-12 | 2005-08-10 | 帕克控股公司 | 处理含烃废物和/或卤化废物的方法 |
US20010031244A1 (en) | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
GB2326334A (en) * | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
BR7702049U (pt) | 1997-09-05 | 1999-09-14 | Chiesi Farma Spa | Bico pulverizador para utilização em inalador oral para medicamentos aerossóis |
NZ504021A (en) * | 1997-10-17 | 2003-04-29 | Systemic Pulmonary Delivery Lt | Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication |
US6045784A (en) * | 1998-05-07 | 2000-04-04 | The Procter & Gamble Company | Aerosol package compositions containing fluorinated hydrocarbon propellants |
SE9802073D0 (sv) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
EP1087750B1 (en) | 1998-06-18 | 2003-11-12 | Boehringer Ingelheim Pharmaceuticals Inc. | Pharmaceutical formulations for aerosols with two or more active substances |
US6451285B2 (en) | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
US6241969B1 (en) | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
ES2234266T3 (es) | 1998-07-24 | 2005-06-16 | Jago Research Ag | Formulaciones medicas para aerosoles. |
EP1102579B1 (de) | 1998-08-04 | 2003-03-19 | Jago Research Ag | Medizinische aerosolformulierungen |
EE04219B1 (et) | 1998-10-17 | 2004-02-16 | Boehringer Ingelheim Pharma Kg | Säilituskindel toimeainekontsentraat formoterooliga |
DE19847969A1 (de) | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Lagerfähig flüssige Formulierung mit Formoterol |
US6086379A (en) * | 1998-10-20 | 2000-07-11 | Research Foundation Of State University Of New York | System and method for training a swimmer |
EP1862164A3 (de) | 1998-11-13 | 2012-12-26 | Jagotec AG | Trockenpulver zur Inhalation |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
US6290930B1 (en) | 1998-12-18 | 2001-09-18 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide |
US6004537A (en) | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
DK1158958T3 (da) | 1999-03-05 | 2007-10-08 | Chiesi Farma Spa | Forbedret pulverformulering til inhalering |
US6315985B1 (en) | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
AU2206801A (en) | 1999-12-24 | 2001-07-09 | Alan Leslie Cripps | Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
IT1318514B1 (it) | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
HU230804B1 (hu) * | 2000-05-22 | 2018-06-28 | Chiesi Farmaceutici S.P.A | Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére |
ATE267591T1 (de) * | 2001-07-02 | 2004-06-15 | Chiesi Farma Spa | Optimierte tobramycin-formulierung zur aerosolbildung |
EP1340492A1 (en) | 2002-03-01 | 2003-09-03 | CHIESI FARMACEUTICI S.p.A. | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
EP1415647A1 (en) * | 2002-10-23 | 2004-05-06 | CHIESI FARMACEUTICI S.p.A. | "Long-acting beta-2 agonists ultrafine formulations" |
JP2005523905A (ja) * | 2002-03-01 | 2005-08-11 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | ホルモテロール(formoterol)超微細調合物 |
US6808684B2 (en) | 2002-04-05 | 2004-10-26 | International Flavors & Fragrance Inc. | Fragrance material |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
-
1999
- 1999-11-22 DZ DZ990247A patent/DZ2947A1/xx active
- 1999-11-23 DK DK99958110T patent/DK1131051T3/da active
- 1999-11-23 JP JP2000583492A patent/JP2002530156A/ja active Pending
- 1999-11-23 US US09/831,888 patent/US7347199B1/en not_active Expired - Fee Related
- 1999-11-23 WO PCT/EP1999/009002 patent/WO2000030608A1/en active Application Filing
- 1999-11-23 DE DE69929358T patent/DE69929358T2/de not_active Expired - Lifetime
- 1999-11-23 GE GEAP19995909A patent/GEP20033129B/en unknown
- 1999-11-23 EA EA200100468A patent/EA004132B1/ru not_active IP Right Cessation
- 1999-11-23 TR TR2001/01441T patent/TR200101441T2/xx unknown
- 1999-11-23 CZ CZ20011834A patent/CZ301305B6/cs not_active IP Right Cessation
- 1999-11-23 PL PL383028A patent/PL204572B1/pl unknown
- 1999-11-23 CN CNB99813743XA patent/CN1200690C/zh not_active Expired - Lifetime
- 1999-11-23 EP EP99958110A patent/EP1131051B1/en not_active Expired - Lifetime
- 1999-11-23 BR BRPI9916868-5A patent/BR9916868B1/pt not_active IP Right Cessation
- 1999-11-23 AT AT99958110T patent/ATE314838T1/de active
- 1999-11-23 TR TR2007/04956T patent/TR200704956T2/xx unknown
- 1999-11-23 HU HU0104411A patent/HU226735B1/hu unknown
- 1999-11-23 SK SK704-2001A patent/SK285246B6/sk not_active IP Right Cessation
- 1999-11-23 EP EP06004954A patent/EP1674079A3/en not_active Withdrawn
- 1999-11-23 CA CA2698376A patent/CA2698376A1/en not_active Abandoned
- 1999-11-23 AT AT05001105T patent/ATE485812T1/de not_active IP Right Cessation
- 1999-11-23 DE DE69942896T patent/DE69942896D1/de not_active Expired - Lifetime
- 1999-11-23 ES ES99958110T patent/ES2255767T3/es not_active Expired - Lifetime
- 1999-11-23 NZ NZ527190A patent/NZ527190A/xx not_active IP Right Cessation
- 1999-11-23 PL PL348717A patent/PL200658B1/pl not_active IP Right Cessation
- 1999-11-23 SI SI9930867T patent/SI1131051T1/sl unknown
- 1999-11-23 EE EEP200100276A patent/EE04259B1/xx unknown
- 1999-11-23 EP EP05001105A patent/EP1523975B1/en not_active Expired - Lifetime
- 1999-11-23 CA CA2352484A patent/CA2352484C/en not_active Expired - Fee Related
- 1999-11-23 KR KR1020017006460A patent/KR100696746B1/ko not_active IP Right Cessation
- 1999-11-23 NZ NZ511926A patent/NZ511926A/en not_active IP Right Cessation
- 1999-11-23 DE DE29923839U patent/DE29923839U1/de not_active Ceased
- 1999-11-23 EP EP06004955A patent/EP1666029A1/en not_active Withdrawn
- 1999-11-23 IL IL14329499A patent/IL143294A0/xx active IP Right Grant
- 1999-11-23 AU AU15563/00A patent/AU764696C/en not_active Ceased
- 1999-11-24 TN TNTNSN99220A patent/TNSN99220A1/fr unknown
- 1999-11-24 TW TW088120515A patent/TWI226247B/zh not_active IP Right Cessation
- 1999-11-24 CO CO99074044A patent/CO5170487A1/es not_active Application Discontinuation
- 1999-11-24 AR ARP990105991A patent/AR021391A1/es not_active Application Discontinuation
- 1999-11-24 EG EG149899A patent/EG25278A/xx active
- 1999-12-13 SA SA99200825A patent/SA99200825B1/ar unknown
-
2001
- 2001-05-22 MA MA26204A patent/MA26764A1/fr unknown
- 2001-05-22 BG BG105532A patent/BG65596B1/bg unknown
- 2001-05-22 NO NO20012516A patent/NO330194B1/no not_active IP Right Cessation
- 2001-05-22 IL IL143294A patent/IL143294A/en not_active IP Right Cessation
-
2002
- 2002-03-11 HK HK02101833.7A patent/HK1040063B/zh not_active IP Right Cessation
- 2002-09-17 US US10/244,519 patent/US7223381B2/en not_active Expired - Fee Related
- 2002-11-08 US US10/290,225 patent/US20030089369A1/en not_active Abandoned
-
2003
- 2003-07-03 US US10/612,072 patent/US7740463B2/en not_active Expired - Fee Related
-
2005
- 2005-02-18 US US11/060,564 patent/US20050142071A1/en not_active Abandoned
-
2006
- 2006-02-07 CY CY20061100154T patent/CY1105356T1/el unknown
- 2006-11-22 IL IL179491A patent/IL179491A0/en unknown
-
2008
- 2008-01-31 US US12/023,315 patent/US8142763B2/en not_active Expired - Fee Related
- 2008-06-04 US US12/132,852 patent/US20080247965A1/en not_active Abandoned
-
2011
- 2011-01-11 US US13/004,204 patent/US20110100361A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5170487A1 (es) | Inhaladores presurizados de dosis medidas (mdi) | |
ES2133130B1 (es) | Nueva formulacion de budesonida, su uso y recipiente que la contiene. | |
ECSP055738A (es) | PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL | |
BR0012046A (pt) | Composto heterocìclico, composição farmacêutica, inibidor de ativação de ap-1 ou um inibidor da ativação de nf-kappab, inibidor da produção de citocina inflamatória, e, inibidor da produção de metaloprotease de matriz ou inibidor da expressão do fator de adesão de célula inflamatória | |
ES2235311T8 (es) | Formulación de budesónida/formoterol para inhalación que tiene una densidad aparente de vertido de 0,30 a 0,36 g/ml, un proceso para preparar la formulación y el uso de la misma. | |
AR021858A1 (es) | Composicion de liberacion modificada de particulas multiples | |
TR200100922T2 (tr) | Aktif maddelerin akciğerler yolu ile tatbik edilmesi. | |
BR0015884A (pt) | Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados | |
EA200401019A1 (ru) | Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества | |
TR200100144T2 (tr) | Farmasötik aerosol formülasyonu | |
UY28348A1 (es) | Compuestos novedosos | |
EA200300999A1 (ru) | Хронотерапевтические дозированные формы | |
ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
HUP9904109A2 (hu) | Külsőleg használandó helyi érzéstelenítő | |
CO5700723A2 (es) | Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca | |
DE60225421D1 (de) | Inhalator mit mitteln zur verbesserung der chemischen stabilität einer darin enthaltenen medizinischen aerosollösung | |
BR0308762A (pt) | Formulação farmacêutica compreendendo melatonina | |
DE60135261D1 (de) | Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält | |
CL2004001421A1 (es) | Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor. | |
UY26171A1 (es) | Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía | |
ES2191206T3 (es) | Nueva utilizacion de la creatina. | |
AR014082A1 (es) | Concentrado oral de sertralina | |
ITMI20021771A1 (it) | Uso di soluzioni attive per la disinfezione e/o sterilizzazione di un riunito dentale e relativo metodo. | |
ITRM20020119A1 (it) | Composizioni contenenti plgf ad uso farmaceutico e cosmetico. | |
AR046955A1 (es) | Preparacion efervescente de una sustancia basica farmaceuticamente activa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |